Tanuj Madan¹*, Jitendra Bothra², Sheetal Raina³, Ahmad Rizvan³, Atul Khullar²and Priya Jose²

¹Assistant Professor, Department of ENT, Military Hospital - Jabalpur, Madhya Pradesh, India
²India Assistant Professor, Department of ENT, Military Hospital - Namkum, Jharkhand, India
³Professor, Department of ENT, Command Hospital- Central Command, Lucknow, India

*Corresponding Author: Tanuj Madan, Assistant Professor, Department of ENT, Military Hospital - Jabalpur, Madhya Pradesh, India

Received: May 05, 2025; Published: May 30, 2025

Abstract

Nasal myiasis is defined as invasion of the nasal cavities by larvae (maggots) of certain dipteran flies. It is a highly unaccustomed Otorhinolaryngological (ORL) emergency with very little literature available. Review of present literature reveals that it occurs in patients with some predisposing factors like immunosuppression, low socio-economic status, mental retardation, chronic granulomatous nasal diseases, long standing and neglected nasogastric tubes etc. Owing to its sporadic nature, the treatment protocols have also varied over time and till date there is no consensus on it. Our reported case is unique from other cases reported so far as our patient was an immunocompetent lady with no known risk factors. She was a homemaker staying in rural setup who also took care of her cattle. The only possible mode of infestation could have been while handling the cows. We managed the case with manual endoscope assisted extraction and turpentine oil irrigation followed by systemic Ivermectin therapy. Patient responded very well to the treatment with all maggots getting removed in a single session. No recurrence occurred till 1 year of follow up.

Keywords: Myiasis; Sinonasal; Ivermectin; Larvae; Maggots; Atrophic Rhinitis; Immunocompetent

References

1. Sinha V., et al. “Nasal myiasis”. Journal of Rhinology2 (2006): 120-123.
2. Davies C., et al. “Combination ivermectin therapy to treat nasal myiasis: A case series”. Otolaryngology Case Reports 27 (2023): 100535.
3. Hope FW. “Transactions of the Royal Entomological Society of London”. 1.4 (1836): lxxviii-xiii.
4. Alebie HK., et al. “Case report:-A case report on pediatrics nasal myiasis with angioedema and literature review”. International Journal of Surgery Case Reports 124 (2024): 110452.
5. Tay SY., et al. “Treatment of nasal myiasis with ivermectin irrigation”. Case Reports (2018): bcr-2017.
6. White ZL., et al. “Nasal myiasis: A case report”. Ear, Nose and Throat Journal7 (2015): E24-25.
7. Rana A., et al. “Otorhinolaryngological myiasis: the problem and its presentations in the weak and forgotten”. Ghana Medical Journal3 (2020): 173-178.
8. Francesconi F and Lupi O. “Myiasis”. Clinical Microbiology Reviews1 (2012): 79-105.
9. Swain SK., et al. “Nasal myiasis in clinical practice”. Apollo Medicine3 (2018): 128-131.
10. Jimenez AG., et al. “Nasal myiasis: an infrequent cause of sinusitis in a critical care patient”. BMJ Case Reports CP1 (2025): e263124.
11. Tai R., et al. “Nasal myiasis caused by Cochliomyia hominivorax in the United States: a case report”. American Journal of Infectious Diseases4 (2011): 107.
12. Crump A. “Ivermectin: enigmatic multifaceted ‘wonder’ drug continues to surprise and exceed expectations”. The Journal of Antibiotics5 (2017): 495-505.

Citation

Citation: Tanuj Madan., et al. “Nasal Myasis in an Immunocompetent Adult: A Rare Case Report from a Zonal Hospital of Central India".Acta Scientific Otolaryngology 7.6 (2025): 34-37.

Copyright

Copyright: © 2025 Tanuj Madan., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.